Clinical-stage biotechnology company focused on developing next-generation radiopharmaceutical therapies for prostate cancer
Location: United States, Massachusetts, Cambridge
Investors 1
| Date | Name | Website |
| 30.08.2023 | OrbiMed | orbimed.co... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 03.05.2023 | Convergent Therapeutics Raises $90M in Series A Funding | Convergent Therapeutics, a Cambridge, MA-based clinical-stage biotechnology company, raised $90M in ... | finsmes.co... |
| - | Convergent Therapeutics | “Convergent Therapeutics – Next-Gen Targeted Radiotherapies” | fastfounde... |